Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

Clinical trial NCT04041310 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04041310
Sponsor: Nouscom SRL
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2019-10-21
Primary completion: 2026-10-30
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.